KHDRBS2
KH domain-containing, RNA-binding, signal transduction-associated protein 2
Also known as: KHDR2_HUMAN, MGC26664, SLM-1, SLM1
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q5VWX1
- Gene
- KHDRBS2
- Ensembl
- ENSG00000112232
- Chromosome
- 6
- Canonical length
- 349 aa
- Protein class
- Predicted intracellular proteins
- Quaternary structure
- Homooligomer
OverviewNCBI Gene
Predicted to enable mRNA binding activity and poly(A) binding activity. Predicted to be involved in regulation of alternative mRNA splicing, via spliceosome. Predicted to be located in nucleoplasm. Predicted to be active in nucleus. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
349 residues, UniProt reviewed canonical sequence.
>Q5VWX1|KHDRBS2
1 MEEEKYLPEL MAEKDSLDPS FVHASRLLAE EIEKFQGSDG KKEDEEKKYL DVISNKNIKL
61 SERVLIPVKQ YPKFNFVGKL LGPRGNSLKR LQEETGAKMS ILGKGSMRDK AKEEELRKSG
121 EAKYAHLSDE LHVLIEVFAP PGEAYSRMSH ALEEIKKFLV PDYNDEIRQE QLRELSYLNG
181 SEDSGRGRGI RGRGIRIAPT APSRGRGGAI PPPPPPGRGV LTPRGSTVTR GALPVPPVAR
241 GVPTPRARGA PTVPGYRAPP PPAHEAYEEY GYDDGYGGEY DDQTYETYDN SYATQTQSVP
301 EYYDYGHGVS EDAYDSYAPE EWATTRSSLK APPQRSARGG YREHPYGRYLocalizationUniProt · AlphaFold · HPA
Whether an antibody against KHDRBS2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.55
- Highest tissue expression
- 6.4 nTPM
Expression across tissuesHPA
Tissue
- basal ganglia: 6.4 nTPM
- thyroid gland: 3.8 nTPM
- hypothalamus: 3.7 nTPM
- retina: 3.7 nTPM
- cerebral cortex: 3.6 nTPM
- lung: 2.1 nTPM
Single-cell type
- retinal bipolar cells: 963 nCPM
- alveolar cells type 1: 827 nCPM
- brain excitatory neurons: 762 nCPM
- brain inhibitory neurons: 718 nCPM
- müller glia: 492 nCPM
- lactotrophs: 477 nCPM
Immune cell
- naive B-cell: 6.9 nTPM
- memory B-cell: 5.9 nTPM
- plasmacytoid DC: 1.9 nTPM
- classical monocyte: 0.3 nTPM
- non-classical monocyte: 0.3 nTPM
- total PBMC: 0.3 nTPM
Brain region
- cerebral cortex: 27 nTPM
- white matter: 19 nTPM
- basal ganglia: 15 nTPM
- hypothalamus: 13 nTPM
- hippocampal formation: 8.9 nTPM
- amygdala: 8.4 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.61
- gnomAD pLI
- 0.04
- gnomAD missense Z
- 0.02
- DepMap mean gene effect
- 0.13
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of KHDRBS2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads KHDRBS2 as an antibody target. Whether an autoantibody or antibody against KHDRBS2 could matter depends on whether native KHDRBS2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
KHDRBS2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label KHDRBS2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...